Real-time enrollment status for this solid tumors with hras alterations clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT06026410 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors With HRAS Alterations |
| Phase | PHASE1 |
| Target Enrollment | 300 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Kura Oncology, Inc. |
| Last Updated on CT.gov | October 14, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT06026410 is currently recruiting participants. This phase1 study for solid tumors with hras alterations is actively seeking new participants at 22 locations across the United States. The study is sponsored by Kura Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06026410 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06026410 was last updated 1 week ago (October 14, 2026). HelloStudys verifies this status automatically.